Skip to main content

Figure 3.

Figure 3

Oncogenic pathway of hepatitis B virus pre‐S mutant proteins. CDK, cyclin dependent kinase; COX‐2, cyclooxygenase‐2; ER, endoplasmic reticulum; IKK, Ikappa B kinase; JAB1, Jun activation domain‐binding protein 1; JNK, Jun N‐terminal kinase; MAPK, mitogen‐activated protein kinase; NKκB, nuclear factor κB; ROS, reactive oxygen species.